Gnosis Vitamin K2 Scientific Advisory Committee Expands & Solidifies Global Presence

Share this article:

Gnosis Vitamin K2 Scientific Advisory Committee Expands & Solidifies Global Presence
The Gnosis Vitamin K2 Scientific Advisory Committee (K2SAC) convened for its very first meeting on November 17th and set the stage for an inspiring journey into the future of Vitamin K2 research. The committee, led by the world-renowned vitamin K2 expert, Professor Leon Schurgers from the University of Maastricht, welcomed two additional members, Dr. Stefanos Roumeliotis and Dr. Sola Bahous. Thus, the committee expands its global reach of top thought leaders, reinforcing its commitment to pioneering advancements in Vitamin K2.

Empowering the Future of Vitamin K2 Science

The inaugural meeting in Lille, France, had Prof. Schurgers alongside the existing members—Hogne Vik, MD, PhD, MBA, and globally renowned K2 expert Katarzyna Maresz—welcomed the additional members who both add valuable experience and expertise that will support the mission to discover and confirm new benefits in the realm of vitamin K2:

  • Stefanos Roumeliotis, MD, from AHEPA University Hospital (Greece), Department of Nephrology, specializes in chronic disease research and statistical analysis and is driving the MenaQ7® K2 VIKIPEDIA study.
  • Sola Bahous, MD, PhD, MHPE, from Lebanese American University School of Medicine, offers expertise including arterial stiffness, pulse wave velocity, hypertension, and renal/kidney failure, and is immersed in the novel migraine study with MenaQ7® Vitamin K2.

 

The morning commenced with an engaging lecture by Prof. Schurgers, delving into the profound impact of Vitamin K2 on “Healthy Aging and the Vitamin K2 Effect.” This insightful session set the tone for a day filled with exploration and collaboration as an expanded team of experts shared their insights from various facets of Vitamin K2 research. It created an ideal setting to address the overarching theme of the meeting: “Exploring the Future of Vitamin K2.” With the committee now strengthened by leaders in K2 research, there is heightened anticipation on the journey to discover and confirm new benefits and applications of this foundational nutrient.

Shaping The Future of Vitamin K2 Through Scientific Collaboration

Gnosis is at the forefront of global Vitamin K2 research. In addition to the K2SAC, Gnosis actively collaborates with other research teams worldwide. This effort provides key insights from clinical studies, uncovering new indications and combinations for Vitamin K2.

Jean-Francois Jeanne, Gnosis Substantiation & Applications Team Manager, summarized the significance of the inaugural K2SAC meeting, stating, “We see our K2SAC galvanizing a worldwide network of esteemed researchers who will focus on identifying specific population needs for K2 and leading the clinical evidence to demonstrate K2’s beneficial use in those areas.”

This commitment underscores Gnosis’ dedication to advancing the understanding and applications of Vitamin K2 to support global health.

CORPORATE HEADQUARTER
101 rue de Menin
59700 Marcq-en-Baroeul
France

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox twice a month.

The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs.